Use of the experimental immune-modulating therapy CNP-104 in adults with primary biliary cholangitis (PBC) participating in a U.S. clinical trial led…
Articles by Marisa Wexler, MS
People whose biological parents were overweight or obese at the time of their conception face a greater risk of early…
One-time treatment with VRON-0200 reduced hepatitis B virus (HBV) levels in the blood of most people with chronic hepatitis…
A new add-on blood test called the FAP-Index may help accurately identify serious liver scarring in people with metabolic…
Daily treatment with Orsobio’s oral candidate TLC-2716 reduces fat levels in both the blood and liver in overweight adults…
Infants with cystic biliary atresia (CBA) tend to undergo standard Kasai surgery earlier than those with other forms of…
A new test that uses a tiny drop of blood collected from a finger prick and returns results in about…
Health Canada has approved Mirum Pharmaceuticals’ oral therapy Livmarli (maralixibat) for cholestatic pruritus — that is, itching due…
An oral tablet formulation of Livmarli (maralixibat) is now approved in Canada to treat pruritus (itching) caused by…
Dosing has begun in a Phase 1/2 clinical trial testing CRMA-1001, Nchroma Bio’s experimental epigenetic therapy being studied as…